These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32647649)

  • 1. The Histone Lysine-specific Demethylase 1 Inhibitor, SP2509 Exerts Cytotoxic Effects against Renal Cancer Cells through Downregulation of Bcl-2 and Mcl-1.
    Wu K; Woo SM; Kwon TK
    J Cancer Prev; 2020 Jun; 25(2):79-86. PubMed ID: 32647649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of LSD1 gene modulates histone methylation and acetylation and induces the apoptosis of JeKo-1 and MOLT-4 cells.
    Zou ZK; Huang YQ; Zou Y; Zheng XK; Ma XD
    Int J Mol Med; 2017 Aug; 40(2):319-328. PubMed ID: 28627608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells.
    Fiskus W; Sharma S; Shah B; Portier BP; Devaraj SG; Liu K; Iyer SP; Bearss D; Bhalla KN
    Leukemia; 2014 Nov; 28(11):2155-64. PubMed ID: 24699304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SP2509, an inhibitor of LSD1, exerts potential antitumor effects by targeting the JAK/STAT3 signaling.
    Zhen H; Zhang X; Zhang L; Zhou M; Lu L; Wu L; He N; Wang J; Li R; Guo Y
    Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(8):1098-1105. PubMed ID: 34169322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SP2509, a Selective Inhibitor of LSD1, Suppresses Retinoblastoma Growth by Downregulating β-catenin Signaling.
    Jiang A; Wu W; Xu C; Mao L; Ao S; Guo H; Sun X; Tao J; Sang Y; Huang G
    Invest Ophthalmol Vis Sci; 2022 Mar; 63(3):20. PubMed ID: 35297943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LSD1 inhibition suppresses the growth of clear cell renal cell carcinoma
    Zhu L; Wang J; Kong W; Huang J; Dong B; Huang Y; Xue W; Zhang J
    Acta Pharm Sin B; 2019 Mar; 9(2):324-334. PubMed ID: 30972280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells.
    Haydn T; Metzger E; Schuele R; Fulda S
    Cell Death Dis; 2017 Jun; 8(6):e2879. PubMed ID: 28617441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lysine-specific demethylase 1 prevents proliferation and mediates cisplatin sensitivity in ovarian cancer cells.
    Shao G; Wan X; Lai W; Wu C; Jin J; Liu X; Wei Y; Lin Q; Zhang L; Shao Q
    Oncol Lett; 2018 Jun; 15(6):9025-9032. PubMed ID: 29928330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LSD1 (KDM1A)-independent effects of the LSD1 inhibitor SP2509 in cancer cells.
    Sonnemann J; Zimmermann M; Marx C; Ebert F; Becker S; Lauterjung ML; Beck JF
    Br J Haematol; 2018 Nov; 183(3):494-497. PubMed ID: 29205263
    [No Abstract]   [Full Text] [Related]  

  • 10. A comprehensive review of lysine-specific demethylase 1 and its roles in cancer.
    Hosseini A; Minucci S
    Epigenomics; 2017 Aug; 9(8):1123-1142. PubMed ID: 28699367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.
    Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y
    J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cafestol overcomes ABT-737 resistance in Mcl-1-overexpressed renal carcinoma Caki cells through downregulation of Mcl-1 expression and upregulation of Bim expression.
    Woo SM; Min KJ; Seo BR; Nam JO; Choi KS; Yoo YH; Kwon TK
    Cell Death Dis; 2014 Nov; 5(11):e1514. PubMed ID: 25375379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysine-specific demethylase LSD1 regulates autophagy in neuroblastoma through SESN2-dependent pathway.
    Ambrosio S; Saccà CD; Amente S; Paladino S; Lania L; Majello B
    Oncogene; 2017 Nov; 36(48):6701-6711. PubMed ID: 28783174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysine-specific demethylase 1 (LSD1) destabilizes p62 and inhibits autophagy in gynecologic malignancies.
    Chao A; Lin CY; Chao AN; Tsai CL; Chen MY; Lee LY; Chang TC; Wang TH; Lai CH; Wang HS
    Oncotarget; 2017 Sep; 8(43):74434-74450. PubMed ID: 29088798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. shRNA-interfering LSD1 inhibits proliferation and invasion of gastric cancer cells
    Pan HM; Lang WY; Yao LJ; Wang Y; Li XL
    World J Gastrointest Oncol; 2019 Aug; 11(8):622-633. PubMed ID: 31435463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lysine-specific demethylase LSD1 induces senescence in Glioblastoma cells through a HIF-1α-dependent pathway.
    Saccà CD; Gorini F; Ambrosio S; Amente S; Faicchia D; Matarese G; Lania L; Majello B
    Biochim Biophys Acta Gene Regul Mech; 2019 May; 1862(5):535-546. PubMed ID: 30951900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of JL1037 as a novel, specific, reversible lysine-specific demethylase 1 inhibitor that induce apoptosis and autophagy of AML cells.
    Liu S; Lu W; Li S; Li S; Liu J; Xing Y; Zhang S; Zhou JZ; Xing H; Xu Y; Rao Q; Deng C; Wang M; Wang J
    Oncotarget; 2017 May; 8(19):31901-31914. PubMed ID: 28404874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1.
    Chen C; Wang Y; Wang S; Liu Y; Zhang J; Xu Y; Zhang Z; Bao W; Wu S
    Int J Oncol; 2017 Mar; 50(3):942-952. PubMed ID: 28098854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of lysine-specific demethylase 1 enhances the sensitivity of hormone-sensitive prostate cancer cells to androgen deprivation therapy.
    Wang M; Liu X; Chen Z; Zhang L; Weng X
    Oncol Lett; 2021 Feb; 21(2):93. PubMed ID: 33376526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JARID1B deletion induced apoptosis in Jeko-1 and HL-60 cell lines.
    Su H; Ma X; Huang Y; Han H; Zou Y; Huang W
    Int J Clin Exp Pathol; 2015; 8(1):171-83. PubMed ID: 25755704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.